Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
key mechanism papers retracted 2025 [4]
Retatrutide 20mg formally designated LY-3437943 is Eli Lillys investigational synthetic triple-receptor agonist peptide that simultaneously activates three key hormone pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor (GCGR)
These can reduce the cost to $25 per prescription, which can cover 1 to 3 months
Some are already widely used as medicines
Use of sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists according to the 2019 ESC guidelines and the 2019 ADA/EASD consensus report in a national population of patients with type 2 diabetes
US$ 23.73
US$ 27.31
US$ 20.23
US$ 29.54
US$ 21.47
US$ 27.91
US$ 27.11
US$ 25.76
US$ 25.86
